LINJARDY MXR 5/10/1000MG TAB

LINJARDY MXR is a combination tablet containing empagliflozin, linagliptin, and metformin HCl. This triple-action formulation is designed to help manage type 2 diabetes by improving blood sugar control through multiple mechanisms: enhancing insulin secretion, reducing glucose reabsorption in the kidneys, and decreasing hepatic glucose production. The extended-release formulation ensures sustained therapeutic effect throughout the day. Suitable for patients requiring comprehensive glycemic management. Always use as directed by your healthcare provider.